Phenytoin-bupropion interaction: effect on plasma phenytoin concentration in the rat
- 1 November 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 42 (11), 799-801
- https://doi.org/10.1111/j.2042-7158.1990.tb07025.x
Abstract
The effect of coadministration of bupropion (50 mg kg−1, p.o.) on the disposition profile of phenytoin has been studied in the rat. Plasma phenytoin concentration was measured serially for 10 h by HPLC. Bupropion had little or no effect on the pharmacokinetic parameters of an acutely administered dose of phenytoin. Following multiple doses of phenytoin however (i.e. steady state) the coadministration of bupropion resulted in significant increases in the elimination half-life (t 1/2), the area under the plasma concentration-time curve (AUC) and the time to maximum plasma concentration (tmax). Allowing for the limitations of single dose studies, these results point to a possible pharmacokinetic interaction between bupropion and phenytoin—the clinical significance of which needs to be assessed.This publication has 7 references indexed in Scilit:
- METABOLISM AND KINETICS OF BUPROPION1983
- Pharmacokinetic Interactions with Antiepileptic DrugsClinical Pharmacokinetics, 1982
- Pharmacokinetics of bupropion, a novel antidepressant agent, following oral administration to healthy subjectsEuropean Journal of Clinical Pharmacology, 1981
- Interaction between phenytoin and imipramine.British Journal of Clinical Pharmacology, 1977
- Phenytoin: Pharmacokinetics and bioavailabilityClinical Pharmacology & Therapeutics, 1976
- Steady‐state plasma nortriptyline concentrations in epileptic patients [letter].British Journal of Clinical Pharmacology, 1975
- Effects of tricyclic antidepressants on drug metabolismClinical Pharmacology & Therapeutics, 1975